Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Labor Relations and Union-Management Negotiation Experts (US)

Analysis of: Insurers Expect Health-Care Costs To Rise More Than 10% Next Year (online.wsj.com)
10% increase in medical spending when the overall cost of living is 1/2 of medical costs and we are happy??
Jason Ma, Board Advisor, Senior Counselor and former CEO
Jason Ma, Board Advisor, Senior Counselor and former CEO
IvyMax, Inc.
Analysis of: California at the Front of Education Trends (www.usnews.com)
1) The Calfornia public K-12 education system has been suffering from budget cuts for decades, is not at the forefront, and is these days among the bottom 10% of the states in terms of standards and results. 2) It used to produce higher-quality student results two decades ago but since...
Jason Ma, Board Advisor, Senior Counselor and former CEO
Jason Ma, Board Advisor, Senior Counselor and former CEO
IvyMax, Inc.
Analysis of: China's Little Dragons (www.forbes.com)
1) Chinese parents in China spend a much higher amount of their annual income on their one child's education, as compared to parents in the U.S., and do almost anything to help their (sometimes spoiled) kids. 2) More and more yuppies in China are increasing their wealth and spend to get ahead in...
Analysis of: UK Says Kidney Cancer Drugs Are Too Pricey (www.pharmalot.com)
Pfizer’s Sutent, Wyeth’s Torisel, Bayer’s Nexavar and Avastin, sold by Roche and Genentech have been deemed too expensive to be paid for by UK agencies
Analysis of: Salmonella Is Tested To Fight Cancer Cells (online.wsj.com)
Salmonella targeting cancer cells? In humans???
Analysis of: Panel Urges End to Prostate Screening at Age 75 (www.nytimes.com)
Since treatment may be worse than the disease it is being recommended that routine prostate cancer screening be stopped after the age of 75.
Analysis of: Amgen Told to Reword Drug Label (www.nytimes.com)
Amgens Aranesp sales fell 26% and J & J's Procrit sales fell 23%."Yaron Werber, a biotechnology analyst at Citi Investment Research, estimated that the new label could reduce the use of Aranesp for cancer patients in this country — the drug is also used by people with kidney disease — by an additional...
Analysis of: Corrections Weaken Cancer Study (online.wsj.com)
Lung cancer screening does not appear to prevent death at least in this study.
Analysis of: Roche Files Avastin for Wider Label in EU (www.therapeuticsdaily.com)
"The filing is supported by data from the phase III Avado trial, which investigated Avastin in combination with docetaxel compared wwith docetaxel alone in the first-line treatment of patients with metastatic breast cancer, Roche said in a statement."
Analysis of: Sorafenib in Advanced Hepatocellular Carcinoma (content.nejm.org)
Sorafenib increases time to progression and median survival in HCC. (World wide a major neoplasm)

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next81 to 90 of 672

Analytics


Generated at 2009-01-07T19:00:58.307